Atlas Trials

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma

Clinical trial NCT00314873 · COMPLETED

Trial details

NCT number
NCT00314873
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Thymic Carcinoma
Start date
2006-04-01
Primary completion
2011-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.